Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
[1] [2] The pharmacokinetic properties of each medication determine its recommended dosing frequencysemaglutide and tirzepatide are typically administered once weekly due to their longer half-lives (approximately one week for semaglutide), whilst liraglutide has a shorter half-life (approximately 13 hours) and requires daily injections
But because their effects have proven to be successful in helping people lose weight, they often are prescribed off-label for that purpose
A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure or type 2 diabetes
GLP-1 may cause serious side effects, including: inflammation of your pancreas (pancreatitis)
One of the reasons we designed our program is to remove the guesswork from the process
Lancet 396 , 909917 (2020)
